Forschungsdatenbank PMU-SQQUID

DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)-a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume
Wurstbauer, K; Deutschmann, H; Dagn, K; Kopp, P; Zehentmayr, F; Lamprecht, B; Porsch, P; Wegleitner, B; Studnicka, M; Sedlmayer, F
RADIAT ONCOL. 2013; 8:
Originalarbeiten (Zeitschrift)

Abstract/Keywords Web of Science PubMed PUBMED Central Full Text

PMU-Autor/inn/en

Deutschmann Heinz
Sedlmayer Felix
Studnicka Michael
Wurstbauer Karl
Zehentmayr Franz

Abstract

Sequential chemo-radiotherapies with intensive radiation components deliver promising results in non-resected non-small cell lung cancer (NSCLC). In general, radiation doses are determined by dose constraints for normal tissues, not by features relevant for tumor control. DART-bid targets directly the doses required for tumor control, correlating doses to tumor volume in a differentiated mode.

Find related publications in this database (Keywords)

Lung cancer
Non-small cell lung cancer
Accelerated radiotherapy
Conformal radiotherapy
Target splitting
Prospective clinical trials
Combined modality
Treatment time
Accelerated repopulation
DART-bid